Cargando…
The Development of Primary Effusion Lymphoma-Like Lymphoma in a Patient with Preexisting Essential Thrombocythemia
A 71-year-old Japanese male was diagnosed with essential thrombocythemia (ET) with the JAK2 V617F mutation variation, in April 2011. He was mainly treated with hydroxyurea following which the number of platelets was maintained within the normal limit. At age 80, he was hospitalized due to cardiac ta...
Autores principales: | Uemura, Yoshiki, Komoto, Marina, Okada, Mitsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452419/ https://www.ncbi.nlm.nih.gov/pubmed/34552800 http://dx.doi.org/10.1155/2021/5237986 |
Ejemplares similares
-
Diagnostic significance of adenosine deaminase in pleural effusate for primary effusion lymphoma–like lymphoma
por: Nakako, Soichiro, et al.
Publicado: (2020) -
Primary Effusion Lymphoma-like ATL Developing during Hemodialysis
por: Masaki, Miharu, et al.
Publicado: (2022) -
Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma
por: Hayashino, Kenta, et al.
Publicado: (2022) -
Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia
por: Song, David, et al.
Publicado: (2023) -
Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia
por: Blouet, Anaïse, et al.
Publicado: (2018)